Dao M. Nguyen, M.D.
Call 305-243-2363 or request an appointment online
- Office: 305-243-2363
- Fax: 305-547-2185
- Thoracic & Cardiac Surgery
- American Board of Thoracic & Cardiac Surgery
- Co-Chair, Disease Specific Group (DSG) - Lung - SCCC
- Member, Thoracic Surgical Oncology, Sylvester Comprehensive Cancer Center
- Professor of Surgery and Chief, Thoracic Surgery Section, Division of Cardiothoracic Surgery, Department of Surgery
Medical education: McGill University, Montreal, Quebec, Canada (MDCM) 1986;
Postgraduate education: general surgery residency (McGill University) 1986-1992; cardiothoracic residency (McGill University) 1992-1994; thoracic oncology (clinical and research fellowship, MD Anderson Cancer Center, University of Texas) 1994-1996; Master of Science (Experimental Surgery, McGill University, 1988-1993).
Academic appointments: Assistant professor (Surgery) McGill University 1996-1998; Principle Investigator (Surgery Branch, Center for Cancer Research) National Cancer Institute, national Institutes of Health, Bethesda, MD 1998-2007; Asssociate professor (surgery) University of Miami, Miami, FL.
Clinical appointments: staff surgeon McGill University Health Center (1996-1998), staff clinician (Surgery Branch, Center for Cancer Research, Warren Magnuson Clinical Center, NIH), chief, section of thoracic surgery, division of cardiothoracic surgery (University of Miami, Jackson Memorial Hospital and University of Miami Hospital, Miami, FL); active member, Sylvester Comprehensive Canncer Center.
Clinical Interest: all aspects of general thoarcic surgery; multi-modality therapy for locally advanced lung cancer, cancer of the esophagus and the pleura and malignant tumors of the mediastinum; phase I, II, III clinical trials for thoracic cancers, novel therapy for lung cancer, medical educations, minimally invasive thoracic surgery
Research Interest: targeted molecular therapy for thoracic cancers (cancers of the lung, the esophagus or the pleura), translational research in receptor-mediated signalings in cancers, anti-angiogenesis